ROBERT DUGGAN
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
VALERIE ANDREWS, FRANK ARMSTRONG, ROBERT BOOTH, ALESSANDRA CESANO, KENNETH CLARK, STEPHEN DAVIES, MICHAEL PAUL DONALDSON, ROBERT W. DUGGAN, GLYN EDWARDS, DANIEL ELGER, RAINER ERDTMANN, CAMILLA GRAHAM, JEFF HUBER, HOUBIERS JOS, UJWALA MAHATME, JIM MELLON, DAVID JOHNATHAN POWELL, BARRY PRICE, DAVID ROBLIN, MOSTAFA RONAGHI, MANMEET SONI, RAYMOND SPENCER, VENTZISLAV STEFANOV, ELAINE STRACKER, DAVID WURZER, YU XIA, LEOPOLDO ZAMBELETTI, MAHKAM ZANGANEH
DIRECTOR
KENNETH CLARK, BRIAN B. DOW, EDWARD EBBERS, SANDRA GARDINER, ROBERT J. GREENBERG, ROBERT LEVANDE, ROBERT M. LEVANDE, MITCHELL LEVINSON, MITCHELL E. LEVINSON, CHRISTOPHER MARLETT, MANMEET SONI, THIERRY B. THAURE, DARRIN UECKER, DARRIN R. UECKER, RICHARD VAN DEN BROEK, AMY WANG, MAHKAM ZANGANEH, MAKY ZANGANEH
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
CHRISTOPHE AURAND, -- AXEBROOK CAPITAL LLP, -- AXEBROOK GP LIMITED, WENDY BEER, JEREMY BLANK, MATTHEW BONANNO, RUSSELL BURT, DAVID DAMAST, JAMES G. DINAN, JOHN J. FOSINA, ZALMAN JACOBS, FRASER MAINGAY, JEANNE L. MANISCHEWITZ, JEANNE M. MANISCHEWITZ, LUIS MEDEIROS, AKBAR RAFIQ, CHRISTIAN REYNTJENS, NATHAN ROMANO, DANIEL A. SCHWARTZ, RONALD SOFER, RICHARD P. SWANSON, JENNIFER THOMSON, WILLIAM C. VRATTOS, JEFFREY A. WEBER, MICHAEL Y. WEINBERGER, MASAHIKO YAMAGUCHI, N/A N/A YORK CAPITAL MANAGEMENT GLOBAL ADVISORS, LLC, N/A N/A YORK GLOBAL CREDIT INCOME DOMESTIC HOLDINGS, LLC
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-09-11
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-06-03
D
OTHER HEALTH CARE
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2021-06-30
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
Equity
2020-11-06

